We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
-2.45%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
–
AUM
$10.1B
AUM Growth
-$4.47B
Cap. Flow
-$3.98B
Cap. Flow %
-39.35%
Top 10 Hldgs %
25.88%
Holding
2,114
New
677
Increased
359
Reduced
350
Closed
725

Top Buys

Rank Stock Value
1
AEE icon
Ameren
AEE
+$161M
2
ETR icon
Entergy
ETR
+$126M
3
DHR icon
Danaher
DHR
+$124M
4
COO icon
Cooper Companies
COO
+$65.6M
5
PPL
PPL Corp
PPL
+$61.3M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$419M
2
CMS icon
CMS Energy
CMS
+$170M
3
DUK icon
Duke Energy
DUK
+$164M
4
C icon
Citigroup
C
+$124M
5
CVX icon
Chevron
CVX
+$108M

Sector Composition

Rank Sector Weight
1 Healthcare 13.02%
2 Utilities 9.78%
3 Financials 9.29%
4 Technology 8.37%
5 Consumer Discretionary 8.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RNG icon
1051
RingCentral
RNG
$5.6B
$640K 0.01%
+25,868
New +$807K
BP icon
1052
BP
BP
$113B
$636K 0.01%
+18,810
New +$614K
HCI icon
1053
HCI Group
HCI
$2.31B
$635K 0.01%
+4,257
New +$540K
CRVS icon
1054
Corvus Pharmaceuticals
CRVS
$1.19B
$634K 0.01%
199,358
+185,842
+1,375% +$875K
L icon
1055
Loews
L
$22.8B
$634K 0.01%
6,893
-43,454
-86% -$3.72M
VET icon
1056
Vermilion Energy
VET
$1.92B
$634K 0.01%
78,300
-61,100
-44% -$546K
GOOD
1057
Gladstone Commercial Corp
GOOD
$638M
$631K 0.01%
+42,150
New +$665K
SAGE
1058
DELISTED
Sage Therapeutics
SAGE
$631K 0.01%
79,360
-60,388
-43% -$442K
GFL icon
1059
GFL Environmental
GFL
$15B
$628K 0.01%
+13,000
New +$589K
SRDX
1060
DELISTED
Surmodics
SRDX
$624K 0.01%
20,443
-30,962
-60% -$1.04M
ACAD icon
1061
Acadia Pharmaceuticals
ACAD
$5.11B
$623K 0.01%
37,491
-33,295
-47% -$605K
CYBR
1062
DELISTED
CyberArk
CYBR
$623K 0.01%
1,844
+1,150
+166% +$413K
NTLA icon
1063
Intellia Therapeutics
NTLA
$1.76B
$623K 0.01%
87,652
-18,175
-17% -$184K
WLFC icon
1064
Willis Lease Finance
WLFC
$1.17B
$621K 0.01%
+11,802
New +$750K
EGY icon
1065
Vaalco Energy
EGY
$608M
$620K 0.01%
+164,946
New +$688K
TFC icon
1066
Truist Financial
TFC
$62.1B
$619K 0.01%
15,039
-922,042
-98% -$41.1M
AHCO icon
1067
AdaptHealth
AHCO
$751M
$614K 0.01%
+56,629
New +$570K
BAP icon
1068
Credicorp
BAP
$30.2B
$614K 0.01%
+3,300
New +$613K
PEB icon
1069
Pebblebrook Hotel Trust
PEB
$2.07B
$612K 0.01%
+60,456
New +$740K
USLM icon
1070
United States Lime & Minerals
USLM
$3.47B
$609K 0.01%
6,895
-524
-7% -$54.5K
LOB icon
1071
Live Oak Bancshares
LOB
$1.87B
$608K 0.01%
+22,787
New +$757K
JAKK icon
1072
Jakks Pacific
JAKK
$292M
$600K 0.01%
+24,331
New +$688K
HIW icon
1073
Highwoods Properties
HIW
$3.5B
$599K 0.01%
20,194
-120,305
-86% -$3.51M
YELP icon
1074
Yelp
YELP
$1.29B
$597K 0.01%
+16,123
New +$606K
TDW icon
1075
Tidewater
TDW
$4.62B
$596K 0.01%
+14,108
New +$702K
41 42
43
44 45

Similar funds

FGP
Freestone Grove Partners San Francisco, California $15.6B AUM 27.39% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
AA
Acorns Advisers Irvine, California $15.3B AUM 18.32% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $15.8B AUM 1.29% 1-Year Est. Return
NMIFOAC
National Mutual Insurance Federation of Agricultural Cooperatives Tokyo, Japan, Japan $15.3B AUM 24.71% 1-Year Est. Return

Michael Gelband's Q1 2025 Portfolio in Review

As of Q1 2025, Michael Gelband held 2,114 positions worth $10.1B, down 31% from $14.6B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Michael Gelband withdrew a net $3.98B in Q1 2025, closing 725 positions and reducing 350 holdings. Its most notable exit was CMS Energy, an estimated $170M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 8% a quarter earlier, followed by Utilities and Financials.

Against the trend, Michael Gelband opened a new position in Ameren worth $168M.

  • Michael Gelband's largest Q1 2025 buy was Ameren: 1,668,398 shares worth $168M.
  • Michael Gelband added most to Danaher in Q1 2025, an estimated $124M increase.
  • Michael Gelband's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $419M.
  • Michael Gelband fully exited CMS Energy in Q1 2025, selling an estimated $170M.
  • Michael Gelband's ten largest holdings make up 26% of its $10.1B portfolio in Q1 2025.
  • Michael Gelband opened 677 new positions and closed 725 in Q1 2025.
  • Michael Gelband's portfolio value fell 31% quarter-over-quarter to $10.1B.

Based on ExodusPoint Capital Management's 13F filing for Q1 2025, filed 14 May 2025.